This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Apr;69(4):599-600.

doi: 10.1016/j.eururo.2015.11.008. Epub 2015 Nov 19.

Utility of Reporting the Percentage of High-grade Prostate Cancer

Lars Egevad¹, Brett Delahunt², Hemamali Samaratunga³, John R Srigley⁴

Affiliations

Affiliations

¹ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: lars.egevad@ki.se.
² Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
³ Aquesta Pathology, Brisbane, Queensland, Australia.
⁴ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

PMID: 26607687
DOI: 10.1016/j.eururo.2015.11.008

Editorial

Utility of Reporting the Percentage of High-grade Prostate Cancer

Lars Egevad et al. Eur Urol. 2016 Apr.

. 2016 Apr;69(4):599-600.

doi: 10.1016/j.eururo.2015.11.008. Epub 2015 Nov 19.

Authors

Lars Egevad¹, Brett Delahunt², Hemamali Samaratunga³, John R Srigley⁴

Affiliations

¹ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: lars.egevad@ki.se.
² Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
³ Aquesta Pathology, Brisbane, Queensland, Australia.
⁴ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

PMID: 26607687
DOI: 10.1016/j.eururo.2015.11.008

No abstract available

PubMed Disclaimer

Comment on

Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter G, Steurer S, Clauditz TS, Krech T, Wittmer C, Lutz F, Lennartz M, Janssen T, Hakimi N, Simon R, von Petersdorff-Campen M, Jacobsen F, von Loga K, Wilczak W, Minner S, Tsourlakis MC, Chirico V, Haese A, Heinzer H, Beyer B, Graefen M, Michl U, Salomon G, Steuber T, Budäus LH, Hekeler E, Malsy-Mink J, Kutzera S, Fraune C, Göbel C, Huland H, Schlomm T. Sauter G, et al. Eur Urol. 2016 Apr;69(4):592-598. doi: 10.1016/j.eururo.2015.10.029. Epub 2015 Nov 2. Eur Urol. 2016. PMID: 26542947

Similar articles

The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ. Ramos CG, et al. J Urol. 1999 Nov;162(5):1587-90. J Urol. 1999. PMID: 10524873
Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.
Horninger W, Volgger H, Rogatsch H, Strohmeyer D, Steiner H, Hobisch A, Klocker H, Bartsch G. Horninger W, et al. J Urol. 2001 Apr;165(4):1143-5. J Urol. 2001. PMID: 11257656
[Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J, Jávor A. Hübler J, et al. Orv Hetil. 1993 Jul 11;134(28):1529-32. Orv Hetil. 1993. PMID: 7688112 Hungarian.
Prostate cancer prevention and finasteride.
D'Amico AV, Barry MJ. D'Amico AV, et al. J Urol. 2006 Nov;176(5):2010-2; discussion 2012-3. doi: 10.1016/j.juro.2006.07.045. J Urol. 2006. PMID: 17070238 Review.
[Prostatic specific antigen: role and significance in urologic practice].
Manolović D, Pejcić T, Milović N. Manolović D, et al. Srp Arh Celok Lek. 1994 May-Jun;122(5-6):171-3. Srp Arh Celok Lek. 1994. PMID: 17977420 Review. Serbian.

See all similar articles

Cited by

Reporting Gleason grade/score in synoptic reports of radical prostatectomies.
Renshaw AA, Mena-Allauca M, Gould EW. Renshaw AA, et al. J Pathol Inform. 2016 Dec 30;7:54. doi: 10.4103/2153-3539.197201. eCollection 2016. J Pathol Inform. 2016. PMID: 28163976 Free PMC article.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.
Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montironi R. Gasparrini S, et al. Asian J Androl. 2017 Aug 4;21(1):19-23. doi: 10.4103/aja.aja_24_17. Online ahead of print. Asian J Androl. 2017. PMID: 28782737 Free PMC article.
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.
Berney DM, Beltran L, Sandu H, Soosay G, Møller H, Scardino P, Murphy J, Ahmad A, Cuzick J; Transatlantic Prostate Group. Berney DM, et al. Histopathology. 2019 Oct;75(4):589-597. doi: 10.1111/his.13888. Epub 2019 Aug 13. Histopathology. 2019. PMID: 31032963 Free PMC article.
Histopathology of Prostate Cancer.
Humphrey PA. Humphrey PA. Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a030411. doi: 10.1101/cshperspect.a030411. Cold Spring Harb Perspect Med. 2017. PMID: 28389514 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information